Metastatic Cholangiocarcinoma

Also known as: Cholangiocarcinoma Metastatic / Metastatic cholangiocarcinoma (morphologic abnormality) / Intrahepatic bile duct carcinoma / Cholangiosarcoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract (disorder) / Cholangiocarcinoma / Cholangiocarcinoma (morphologic abnormality)

DrugDrug NameDrug Description
DB14568IvosidenibAn isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation.
DrugDrug NamePhaseStatusCount
DB00041Aldesleukin1Terminated1
DB14547Chloride ion1Active Not Recruiting1
DB00515Cisplatin1Active Not Recruiting1
DB00531Cyclophosphamide1Terminated1
DB00441Gemcitabine1Active Not Recruiting1
DB14568Ivosidenib1Active Not Recruiting1
DB09037Pembrolizumab1Terminated1
DB15102Pemigatinib1Active Not Recruiting1
DB12257Platinum1Active Not Recruiting1
DB11595Atezolizumab2Completed1
DB00958Carboplatin2Active Not Recruiting1
DB00515Cisplatin2Recruiting1
DB05239Cobimetinib2Completed1
DB11714Durvalumab2Recruiting1
DB11841Entinostat2Completed1
DB00544Fluorouracil2Completed1
DB00441Gemcitabine2Recruiting1
DB14568Ivosidenib2Recruiting1
DB00650Leucovorin2Completed1
DB09035Nivolumab2Completed1
DB01229Paclitaxel2Active Not Recruiting1
DB11759Pevonedistat2Active Not Recruiting1
DB05482SN-382Recruiting1
DB12893Sacituzumab govitecan2Recruiting1
DB17384Tinengotinib2Recruiting1
DB00515Cisplatin3Recruiting1
DB00441Gemcitabine3Recruiting1
DB14568Ivosidenib3Completed1
DB15102Pemigatinib3Recruiting1